RxDoctor Payments Data

Gil Roter, MD

Internal Medicine · New York, NYNPI 1073621231

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 15th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Medicare billing

Part B allowed, 2024
$1,950,514
Medicare patients
2,054
Services billed
24,726

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban119$104,051
JanuviaSitagliptin Phosphate47$44,349
XareltoRivaroxaban25$20,164
OzempicSemaglutide12$11,818
SantylCollagenase Clostridium Hist.23$9,095
Advair HfaFluticasone Propion/Salmeterol11$5,152
Lacosamide17$4,444
Breo ElliptaFluticasone/Vilanterol11$4,005
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$2,898
Insulin Lispro Kwikpen U-100Insulin Lispro16$2,468
Mirtazapine75$2,403
Atorvastatin Calcium227$2,386
Gabapentin95$2,364
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip72$2,142
Levetiracetam33$1,842

Paid to pharmacies, not to this prescriber.

Other internal medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →